Infectious Diseases

Michael Banks, MD, talks about how 2016 Medicaid criteria has allowed for increased access to direct-acting antiviral therapies among patients with hepatitis C virus for whom the costs of the treatments...

Michael Banks, MD, discusses a recent study that details the inconsistencies of antiviral treatment in children hospitalized with an influenza infection, despite recommendations from the Centers for Disease...

Walter H. Koch, PhD, discusses the expansion of research on the Zika virus in response to last year's outbreak.

Michael Banks, MD, discusses the results of a 2016 study that suggested that nasal spray might not be an effective vaccination tool.

Edmund J. Lavoie, PhD, discusses the unique pharmacokinetic properties of the experimental drug TXA-709 that may allow it to effectively treat Staphylococcus aureus infections, including MRSA, while...

Robert M. Strauss, MD, gastroenterologist, GI Specialists of Georgia, gives an overview of the characteristics and pathology of Clostridium difficile. He explains that when the population of good...